
Neomangiferin | CAS:64809-67-2
Neomangiferin
- 名称:新芒果苷; 新杧果苷 | Neomangiferin
- CAS号:64809-67-2
- 别名:2-beta-D-Glucopyranosyl-7-(b-D-glucopyranosyloxy)-1,3,6-trihydroxy-9H-xanthen-9-one
- 分子式:C25H28O16
- 分子量:584.48
- EINESC号:
产品描述
物理化学性质
密度 | 1.839 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Synthesis of 4-(aminoalkyl) substituted 1,3-dioxanes as potent NMDA and σ receptor antagonists.Tina Utech et al.European journal of medicinal chemistry, 46(6), 2157-2169 (2011-03-30)
NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds.Michael L Berger et al.Bioorganic & medicinal chemistry, 17(9), 3456-3462 (2009-04-07)
Physicochemical determinants of human renal clearance.Manthena V S Varma et al.Journal of medicinal chemistry, 52(15), 4844-4852 (2009-05-19)
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.Larry J Jolivette et al.Journal of pharmaceutical sciences, 94(7), 1467-1483 (2005-05-28)
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.E Fontana et al.Current drug metabolism, 6(5), 413-454 (2005-10-27)
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.Manthena V S Varma et al.Journal of medicinal chemistry, 53(3), 1098-1108 (2010-01-15)
Novel analogues of ketamine and phencyclidine as NMDA receptor antagonists.Paola Zarantonello et al.Bioorganic & medicinal chemistry letters, 21(7), 2059-2063 (2011-02-22)
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.Michael H Abraham et al.European journal of medicinal chemistry, 43(3), 478-485 (2007-06-05)
Hologram QSAR model for the prediction of human oral bioavailability.Tiago L Moda et al.Bioorganic & medicinal chemistry, 15(24), 7738-7745 (2007-09-18)
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.R Scott Obach et al.Drug metabolism and disposition: the biological fate of chemicals, 36(7), 1385-1405 (2008-04-23)
QSAR-based permeability model for drug-like compounds.Rafael Gozalbes et al.Bioorganic & medicinal chemistry, 19(8), 2615-2624 (2011-04-05)
Synthesis of bridged piperazines with sigma receptor affinity.Manuela Weigl et al.European journal of medicinal chemistry, 42(10), 1247-1262 (2007-04-11)
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.Lei Du-Cuny et al.Bioorganic & medicinal chemistry, 17(19), 6983-6992 (2009-09-08)
Adaptive neuro-fuzzy inference system (ANFIS): a new approach to predictive modeling in QSAR applications: a study of neuro-fuzzy modeling of PCP-based NMDA receptor antagonists.Erdem Buyukbingol et al.Bioorganic & medicinal chemistry, 15(12), 4265-4282 (2007-04-17)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!